Northern Trust’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $65.2M | Buy |
868,179
+21,461
| +3% | +$1.69M | 0.01% | 955 |
|
|
2025
Q4 | $67M | Buy |
846,718
+1,775
| +0.2% | +$134K | 0.01% | 940 |
|
|
2025
Q3 | $55.3M | Buy |
844,943
+30,693
| +4% | +$1.5M | 0.01% | 1070 |
|
|
2025
Q2 | $32.2M | Sell |
814,250
-20,597
| -2% | -$674K | ﹤0.01% | 1369 |
|
|
2025
Q1 | $25.2M | Sell |
834,847
-5,424
| -0.6% | -$178K | ﹤0.01% | 1492 |
|
|
2024
Q4 | $29.4M | Buy |
840,271
+97,367
| +13% | +$3.64M | ﹤0.01% | 1456 |
|
|
2024
Q3 | $29.8M | Buy |
742,904
+24,929
| +3% | +$1.16M | ﹤0.01% | 1376 |
|
|
2024
Q2 | $34.2M | Buy |
717,975
+25,728
| +4% | +$1.06M | 0.01% | 1217 |
|
|
2024
Q1 | $30M | Buy |
692,247
+4,261
| +0.6% | +$203K | 0.01% | 1322 |
|
|
2023
Q4 | $34.8M | Sell |
687,986
-2,738
| -0.4% | -$131K | 0.01% | 1261 |
|
|
2023
Q3 | $31.3M | Buy |
690,724
+19,646
| +3% | +$811K | 0.01% | 1248 |
|
|
2023
Q2 | $27.5M | Buy |
671,078
+12,612
| +2% | +$485K | 0.01% | 1381 |
|
|
2023
Q1 | $23.5M | Buy |
658,466
+18,777
| +3% | +$705K | ﹤0.01% | 1452 |
|
|
2022
Q4 | $24.2M | Buy |
639,689
+16,049
| +3% | +$675K | 0.01% | 1409 |
|
|
2022
Q3 | $27.6M | Sell |
623,640
-1,832
| -0.3% | -$77.2K | 0.01% | 1251 |
|
|
2022
Q2 | $23.2M | Sell |
625,472
-23,062
| -4% | -$870K | 0.01% | 1425 |
|
|
2022
Q1 | $24M | Sell |
648,534
-12,356
| -2% | -$404K | ﹤0.01% | 1540 |
|
|
2021
Q4 | $20.1M | Buy |
660,890
+5,469
| +0.8% | +$172K | ﹤0.01% | 1767 |
|
|
2021
Q3 | $22M | Sell |
655,421
-16,152
| -2% | -$609K | ﹤0.01% | 1735 |
|
|
2021
Q2 | $26.8M | Sell |
671,573
-169,572
| -20% | -$6.64M | ﹤0.01% | 1685 |
|
|
2021
Q1 | $37.8M | Buy |
841,145
+15,971
| +2% | +$891K | 0.01% | 1345 |
|
|
2020
Q4 | $46.7M | Sell |
825,174
-6,362
| -0.8% | -$317K | 0.01% | 1121 |
|
|
2020
Q3 | $39.5M | Buy |
831,536
+939
| +0.1% | +$52.2K | 0.01% | 1074 |
|
|
2020
Q2 | $49M | Sell |
830,597
-4,896
| -0.6% | -$272K | 0.01% | 909 |
|
|
2020
Q1 | $39.5M | Buy |
835,493
+37,206
| +5% | +$2.07M | 0.01% | 914 |
|
|
2019
Q4 | $48.2M | Sell |
798,287
-971
| -0.1% | -$57.9K | 0.01% | 1044 |
|
|
2019
Q3 | $47.9M | Sell |
799,258
-6,639
| -0.8% | -$433K | 0.01% | 1009 |
|
|
2019
Q2 | $51.8M | Buy |
805,897
+153,326
| +23% | +$10.8M | 0.01% | 971 |
|
|
2019
Q1 | $53M | Buy |
652,571
+5,781
| +0.9% | +$373K | 0.01% | 920 |
|
|
2018
Q4 | $35M | Buy |
646,790
+6,578
| +1% | +$335K | 0.01% | 1125 |
|
|
2018
Q3 | $33M | Buy |
640,212
+18,569
| +3% | +$872K | 0.01% | 1368 |
|
|
2018
Q2 | $25.9M | Buy |
621,643
+21,286
| +4% | +$944K | 0.01% | 1566 |
|
|
2018
Q1 | $26.5M | Buy |
600,357
+13,375
| +2% | +$679K | 0.01% | 1470 |
|
|
2017
Q4 | $29.5M | Sell |
586,982
-4,396
| -0.7% | -$241K | 0.01% | 1407 |
|
|
2017
Q3 | $30M | Sell |
591,378
-30,438
| -5% | -$1.59M | 0.01% | 1384 |
|
|
2017
Q2 | $31.6M | Buy |
621,816
+44,750
| +8% | +$2.08M | 0.01% | 1319 |
|
|
2017
Q1 | $23.2M | Buy |
577,066
+65,978
| +13% | +$2.96M | 0.01% | 1535 |
|
|
2016
Q4 | $24.4M | Buy |
511,088
+2,604
| +0.5% | +$103K | 0.01% | 1453 |
|
|
2016
Q3 | $18.6M | Sell |
508,484
-65,601
| -11% | -$2.05M | 0.01% | 1648 |
|
|
2016
Q2 | $13.4M | Buy |
574,085
+24,171
| +4% | +$780K | ﹤0.01% | 1819 |
|
|
2016
Q1 | $22.3M | Buy |
549,914
+10,488
| +2% | +$426K | 0.01% | 1413 |
|
|
2015
Q4 | $33.4M | Sell |
539,426
-87,649
| -14% | -$4.73M | 0.01% | 1087 |
|
|
2015
Q3 | $25.3M | Sell |
627,075
-771,179
| -55% | -$39.9M | 0.01% | 1316 |
|
|
2015
Q2 | $80.5M | Sell |
1,398,254
-172,965
| -11% | -$11M | 0.02% | 594 |
|
|
2015
Q1 | $100M | Buy |
1,571,219
+224,326
| +17% | +$15.2M | 0.03% | 510 |
|
|
2014
Q4 | $83.2M | Sell |
1,346,893
-32,489
| -2% | -$1.6M | 0.03% | 567 |
|
|
2014
Q3 | $53.6M | Buy |
1,379,382
+22,070
| +2% | +$782K | 0.02% | 739 |
|
|
2014
Q2 | $46.8M | Sell |
1,357,312
-165,315
| -11% | -$5.21M | 0.01% | 842 |
|
|
2014
Q1 | $65.8M | Sell |
1,522,627
-142,509
| -9% | -$6.91M | 0.02% | 657 |
|
|
2013
Q4 | $66.3M | Buy |
1,665,136
+43,518
| +3% | +$1.55M | 0.02% | 614 |
|
|
2013
Q3 | $60.9M | Sell |
1,621,618
-17,003
| -1% | -$508K | 0.02% | 609 |
|
|
2013
Q2 | $44M | Buy |
+1,638,621
| New | +$34.8M | 0.02% | 734 |
|
Other funds holding IONS
VPM
VCM
Northern Trust's IONS Position: Q1 2026 in Review
Northern Trust increased its Ionis Pharmaceuticals (IONS) stake by 2.5% in Q1 2026, buying an estimated $1.69M and bringing the position to 868,179 shares worth $65.2M. The position accounts for 0.01% of the portfolio, ranked #955.
Northern Trust first reported a position in IONS in Q2 2013 and has held it in 52 quarters since. The position peaked at $100M in Q1 2015. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.
- Northern Trust held 868,179 shares of Ionis Pharmaceuticals worth $65.2M as of Q1 2026.
- Northern Trust bought 21,461 Ionis Pharmaceuticals shares in Q1 2026, an estimated $1.69M.
- Ionis Pharmaceuticals made up 0.01% of Northern Trust's portfolio in Q1 2026, its #955 holding.
- Northern Trust first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Northern Trust's Ionis Pharmaceuticals position peaked at $100M in Q1 2015.
- 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.